This site is intended for healthcare professionals only
LoginRegister

Oncology Dialogues

Sanofi Commits USD 625 Million to Sanofi Ventures to Boost Biotech and Digital Health Startups

Sanofi multiple myeloma drug Sarclisa phase 3 trial meets primary endpoint of progression-free...

Paris: Sanofi has announced that the Phase 3 IMROZ trial evaluating the investigational use of Sarclisa (isatuximab) in combination with...
View All

Latest News and Guidelines

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck-Eisai endometrial cancer therapy combo fails first-line treatment trial

Pfizer discontinues development of danuglipron for chronic weight management

Pfizer Elrexfio gets European Commission approval for Multiple Myeloma

Use of GLP-1 drugs in type 2 diabetes tied to reduced risk of colorectal cancer: JAMA

Use of GLP-1 drugs in type 2 diabetes tied to reduced risk of colorectal cancer: JAMA

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb Abecma approved for use in earlier lines of therapy for patients with relapsed...

Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment

USFDA accepts for priority review Bristol Myers Squibb application for Opdivo plus Cisplatin-Based...

View All
X